Abstract-Epidermal growth factor receptor tyrosine kinase (EGFRtk) and endoplasmic reticulum (ER) stress are important factors in cardiovascular complications. Understanding whether enhanced EGFRtk activity and ER stress induction are involved in cardiac damage, and microvascular dysfunction in type 1 diabetes mellitus is an important question that has remained unanswered. Cardiac fibrosis and microvascular function were determined in C57BL/6J mice injected with streptozotocin only or in combination with EGFRtk inhibitor (AG1478), ER stress inhibitor (Tudca), or insulin for 2 weeks.
D iabetes mellitus is a major cause of morbidity and mortality worldwide and is a threat to human health. 1, 2 Increasing evidence from experimental and clinical studies indicates a higher prevalence of cardiac damage and microvascular complications in diabetic patients. [3] [4] [5] [6] [7] Epidermal growth factor receptor (EGFR) is a glycoprotein containing a single transmembrane domain with intracellular portion harboring the tyrosine kinase domain. The EGFRtk is regulated by glucose through EGFR-N-glycosylation, 8 and although there is a plethora of information on the growth-promoting effects of EGFR, its role in cardiovascular complications in type 1 diabetes mellitus remains unknown. We and others have demonstrated that increased EGFRtk phosphorylation contributes to resistance artery dysfunction in type 2 diabetes mellitus. 9, 10 In addition, it has been reported that the inhibition of EGFR activity promotes vasodilatation and reduces elevated arterial blood pressure in hypertensive animal models with or without insulin resistance. 11, 12 Recently, several studies in different cancer cell lines and human tissues have reported a relationship between aberrant EGFRtk expression-activation and endoplasmic reticulum (ER) stress-related proteins. 13, 14 ER stress plays a critical role in the pathogenesis of diabetes mellitus and associated cardiovascular complications. 15, 16 Various cellular stresses, including ischemia, hypoxia, gene mutation, oxidative stress, and protein synthesis overload, lead to impairment of ER function and create a state termed "ER stress" that leads to the activation of a complex signaling network called the unfolded protein response. 17, 18 The unfolded protein response is regulated in the cell by 3 ER membrane-associated proteins that act as sensors of ER homeostasis. The 3 membrane-bound protein are protein kinase-like ER eukaryotic initiation factor 2␣ kinase, inositol requiring ER-to-nucleus signaling protein-1␣, and activating transcription factor 6 (ATF6). The involvement of ER stress in the development of diseases, such as obesity, stroke, myocardial ischemia, and type 2 diabetes mellitus, has been widely demonstrated and is considered a key element in pancreatic ␤-cell dysfunction and peripheral insulin resistance. [18] [19] [20] [21] [22] [23] The significance and role of exacerbated EGFRtk and ER stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus are important questions that have remained unanswered. Thus, the aim of this study was to determine the role of increased EGFRtk activity and its downstream ER stress as important factors in cardiac damage and microvascular dysfunction in the type 1 diabetic mouse model.
Materials and Methods
See the online-only Data Supplement.
Results

Effect of EGFRtk Inhibition on Glucose Level, Body Weight, Cardiac Fibrosis, and ER Stress Markers in the Heart
The induction of type 1 diabetes mellitus with streptozotocin (STZ) injection increased blood glucose levels to 408% compared with control mice (100%; Figure 1A ), decreased the body weight to 40% ( Figure 1B) , and induced cardiac fibrosis associated with increased plasminogen activator inhibitor (PAI) 1 (3.5-fold) and collagen type 1 expression (3-fold; Figure 1C through 1E). In STZ mice, the inhibition of EGFRtk reduced blood glucose level to 337% and increased the body weight to 84% ( Figure 1A and 1B). Fibrosis was reduced by 50%, and collagen type 1 expression was reduced to 2-fold compared with STZ mice, whereas PAI-1 was blunted ( Figure 1C through 1E) . Interestingly, the mRNA levels and phosphorylation of EGFRtk were augmented by 2.5-and 2.0-fold, respectively, in cardiac tissue from STZ mice and were significantly reduced after EGFRtk inhibition ( Figure 1F and 1G) . ER stress marker expression assessed by real-time RT-PCR revealed an increase by 2.0-and 2.5-fold for CHOP, ATF4, and ATF6, respectively, in cardiac tissue from STZ mice and were reduced after EGFRtk inhibition, with the exception of ATF6 ( Figure 1H , 1J, and 1K). The protein expression of CHOP was increased by 4-fold in STZ mice and blunted after EGFRtk inhibition ( Figure 1I ).
Effect of ER Stress Inhibition on Glucose Level, Body Weight, Insulin, Cardiac Fibrosis, and ER Stress Markers in the Heart
The injection of STZ significantly increased blood glucose concentration to 436% compared with control mice (100%) and was significantly reduced to 326% after ER stress inhibition and normalized with insulin injection (94%; Figure  2A ). The ER stress inhibition increased body weight from 58% in STZ mice to 72%, whereas the treatment with insulin completely restored the body weight to control mice value ( Figure 2B ). Insulin level was not detectable in STZ mice treated with or without Tudca (0.036Ϯ0.0 and 0.035Ϯ0.0 ng/L, respectively) but was restored with insulin treatment (0.99Ϯ0.2 ng/L; Figure 2C ).
We observed cardiac fibrosis induction in STZ mice evidenced by an increase in collagen type I deposition and an increase by 2.5-and 2.0-fold in PAI-1 and collagen type 1 expression, respectively, which were blunted with Tudca and insulin treatments ( Figure 2D through 2F). The cardiac fibrosis in STZ mice was associated with ER stress evidenced by augmented mRNA levels of ATF4 (2.5-fold), CHOP (3.0-fold), and ATF6 (2.5-fold), which were reduced with Tudca and insulin treatment to control levels ( Figure 2G , 2I, and 2J). The expression of CHOP was increased by 3.5-fold in STZ mice and was blunted after insulin treatment and ER stress inhibition ( Figure 2H ). In addition, Western blot analysis in heart showed no changes in EGFRtk phosphorylation in the STZ group compared with the STZϩTudca group ( Figure S1A ).
Effect of EGFRtk Inhibition on Vascular Relaxation and ER Stress Markers in Mesenteric Resistance Arteries
The EGFRtk expression in mesenteric resistance arteries (MRAs) assessed by Western blot and real-time RT-PCR revealed no changes in all of the groups of mice ( Figure 3A and 3B), whereas phosphorylated EGFRtk was 2-fold increased in MRA from STZ mice compared with control and diabetic mice treated with the EGFRtk inhibitor ( Figure 3B ).
To determine the role of EGFRtk in microvascular dysfunction in type 1 diabetes mellitus, we examined the endothelium-dependent relaxation (EDR) response in MRA from STZ mice infused with and without EGFRtk inhibitor. EDR was significantly decreased in STZ mice (33.6%) compared with control (84%; Figure 3C ) and was associated with reduced endothelial NO synthase (eNOS) expression and phosphorylation and cGMP levels ( Figure 3E and 3F). Endothelium-independent relaxation was shifted to the right in STZ mice (EC 50 ϭ6.3Ϯ0.07) compared with control mice (EC 50 ϭ7.29Ϯ0.03; Figure 3D ). Importantly, the inhibition of EGFRtk in STZ mice improved EDR (76.6%), restored endothelial independent sensitivity (EC 50 ϭ7.47Ϯ0.04), increased by 2-fold eNOS phosphorylation, and restored cGMP levels to control in MRAs ( Figure 3C through 3F) .
The phosphorylation of eIF2␣ and mRNA levels of CHOP, ATF4, and ATF6 were increased by 3.0-, 2.5-, 4.0-, and 7.0-fold, respectively, in MRAs from STZ mice compared with control mice and were reduced after EGFRtk inhibition by 2.5-, 1.6-, and 2.8-fold, respectively, with the exception of the Effect of epidermal growth factor receptor (EGFR) tyrosine kinase (EGFRtk) inhibition on plasma glucose, body weight, fibrosis, EGFRtk, and endoplasmic reticulum (ER) stress markers in heart from streptozotocin (STZ) mice. A and B, Glucose levels (mg/dL) and body weight (BW) were determined in control, STZ, and STZϩAG1478 groups; nϭ7. The vertical dashed lines denote the start of infusion of AG1478. , control; ࡗ, STZϩAG1478; e, STZ. C, Representative histological sections from the heart stained with Siriusred; bars indicate the quantitative data, nϭ5. D and E, Representative Western blot analysis and quantitative data for plasminogen activator inhibitor (PAI) 1 and collagen I in heart in all groups, nϭ4 to 5. F and G, EGFR mRNA levels, nϭ5 and representative Western blot analysis and quantitative data for phosphorylated EGFR and total EGFR in all groups; nϭ5. H and I, CHOP mRNA levels, nϭ5, and CHOP representative Western blot and quantitative data in all groups, nϭ3. J and K, ATF-4 and ATF-6 mRNA levels, normalized to 18S rRNA, in all of the groups, nϭ5. *PϽ0.05 for STZ vs control; #PϽ0.05 for STZ vs STZϩAG1478; $PϽ0.05 for STZϩAG1478 vs control. Effect of endoplasmic reticulum (ER) stress inhibition on plasma glucose, body weight, plasma insulin, cardiac fibrosis, and ER stress markers expression in heart from streptozotocin (STZ) mice. A and B, Glucose levels (mg/dL) and body weight (BW) were determined in control, STZ, STZϩinsulin, and STZϩTudca groups; nϭ10. The vertical dashed lines denote the start of the injection of insulin or Tudca. ࡗ, control; OE, STZϩinsulin; e, STZ; OE, STZϩTudca. C, Plasma insulin levels (ng/dL) in all groups, nϭ10. D, Representative histological sections from the heart stained with Sirius-red, bars indicate the quantitative data, nϭ5. E and F, Representative Western blot analysis and quantitative data for plasminogen activator inhibitor (PAI) 1 and collagen I in heart from all of the groups, nϭ4 to 5. G and H, CHOP mRNA levels, nϭ5, and CHOP representative Western blot and quantitative data in all groups, nϭ3. I and J, ATF-4 and ATF-6 mRNA levels, normalized to 18S rRNA, in all groups, nϭ5 to 6. 
Effect of ER Stress Inhibition on Microvascular Function in MRAs
To delineate the role of ER stress in microvascular dysfunction in type 1 diabetes mellitus, we first examined EDR response in MRAs from STZ mice with or without Tudca or insulin. EDR was significantly improved in STZ mice treated with Tudca or insulin (61.3% and 84.3%, respectively; Figure  4A ). Endothelium-independent relaxation was shifted to the right in STZ mice (EC 50 ϭ6.27Ϯ0.05) and was normalized after ER stress inhibition (EC 50 ϭ6.94Ϯ0.05) or insulin injection (EC 50 ϭ7.43Ϯ0.06; Figure 4B ). These results were supported with the measurements of eNOS phosphorylation and expression and cGMP level, which were decreased by 4.0-, 3.0-, and 2.5-fold, respectively, in STZ mice and were normalized with Tudca and insulin treatments ( Figure 4C and 4D). Microvascular endothelial dysfunction in STZ mice was associated with ER stress induction, as evidenced by enhanced phosphorylated eIF2␣ (4-fold) and the increase in the mRNA levels of ATF4 (4.5-fold), CHOP (3.0-fold), and ATF6 (9.0-fold; Figure 4E through 4H). Interestingly, insulin and ER stress inhibition (Tudca) were able to significantly reduce ER stress marker expression in MRAs from STZ mice ( Figure 4E through 4H) . The total eIF2␣ protein expression was similar in all of the groups of mice. In addition, EGFRtk phosphorylation in MRAs was similar in the STZ and STZϩTudca groups ( Figure S1B ). The inhibition of NOsynthesis (N G -nitro-L-arginine methyl ester; 100 mol/L) reduced EDR by 17.3% in STZ mice, whereas a great reduction was observed in control and STZ mice treated with AG1478 (40%), Tudca (40%), or insulin (64%; Figure 5A through 5E).
To determine the link between ER stress and reactive oxygen species in microvascular endothelial dysfunction, we incubated MRAs with apocynin (100 mol/L). The results revealed that apocynin significantly improved EDR in STZ mice (25%), whereas no effect was observed in control or STZ mice treated with AG1478, Tudca, or insulin ( Figure 5A through 5E). The enhanced mRNA levels of Nox2 and Nox4 isoforms by 4-and 6-fold, respectively, in MRA from STZ mice supported these findings, which were blunted after inhibition of EGFRtk, ER stress, or insulin injection ( Figure  5F through 5I) . Moreover, the NADPH oxidase activity, determined in heart and MRA lysates, was increased in STZ mice by 3-and 4-fold, respectively, compared with control mice. The inhibition of EGFRtk and ER stress significantly decreased this activity ( Figure S1C and S1D).
Effect of ER Stress Induction by Tunicamycin on Phosphorylated EGFR Expression in Heart and MRAs
The EGFRtk phosphorylation in heart and MRAs was similar in control and mice injected with Tunicamycin with and without Tudca ( Figure S2A and S2B ). In addition, the phosphorylated EGFRtk expression, in MRAs, remained unchanged in all of the groups ( Figure S2C ).
Discussion
In the present study, we found that EGFRtk phosphorylation and expression were upregulated in heart and microvessels of diabetic mice and were associated with ER stress induction, cardiac fibrosis, and microvascular endothelial dysfunction. Our results are supported by previous studies reporting that EGFRtk inhibition improved microvascular function in type 2 diabetes mellitus. 9, 10 Interestingly, the inhibition of EGFRtk improved glucose levels, body weight, and microvascular function and reduced cardiac fibrosis and ER stress markers, with the exception of ATF6. These results suggest that exacerbated EGFRtk phosphorylation regulates cardiovascular dysfunction and metabolic alteration in type 1 diabetes mellitus, likely through phosphorylated protein kinase-like ER eukaryotic initiation factor 2␣ kinase-ATF4-derived ER stress branch but independent of the ATF6 branch.
Emerging evidence from experimental and clinical studies indicate that ER stress plays an important role in cardiovascular diseases 17 and diabetes mellitus, as evidenced by peripheral insulin resistance and pancreatic ␤-cell dysfunction 22, 23 related to ER stress. 15, 19 In addition, ER stress has been demonstrated to be involved in the development of diabetes mellitus affecting different organs like liver, kidney, and skeletal muscle in several models of diabetic animals 15, 24, 25 ; however, the role and mechanisms of ER stress in cardiac fibrosis and microvascular endothelial dysfunction in type 1 diabetes mellitus remain unclear. Previous studies have shown that ER stress is associated with heart failure and cardiomyopathy in nondiabetic and diabetic animals supporting the potential role of ER stress in cardiac damage. [26] [27] [28] In the present work, we found that ER stress induction and cardiac fibrosis were associated with enhanced collagen type 1 and PAI-1 expression in diabetic mice. The inhibition of EGFRtk and ER stress reduced ER stress markers, suggesting that EGFRtk is upstream to ER stress activation. These data are supported by a recent publication showing that overexpression of aberrant EGFRtk in several cancers induces the expression of CHOP.
14 In addition, chemical inhibition of EGFRtk and ER stress reduced cardiac fibrosis, collagen type 1, and PAI-1. Although the reduction on myocardial fibrosis appears pronounced in these animals, the effect of AG1487 and Tudca on blood glucose levels is modest, indicating that these drugs may act by mechanisms independent of their hypoglycemic effects. These results suggest that cardiac fibrosis in type 1 diabetes mellitus is regulated by an ER stressdependent mechanism. However, it is unclear how ER stress controls collagen type 1 turnover, and additional studies are needed to delineate the mechanism. It is well established that diabetes mellitus impairs microvascular function. 29 It is known that hyperglycemia causes an enhancement in advanced glycation end products, oxidative stress levels, and increases EGFR tyrosine kinase activity leading to microvascular endothelial dysfunction, in part through the loss of NO bioavailability. 9, [30] [31] [32] The impaired EDR was also associated with a decrease in eNOS phosphorylation and expression in diabetic mice. These results are supported by previous studies showing a decrease in eNOS mRNA levels in KKAy mice 33 and reduced eNOS phosphorylation in diabetic mice. 9 Importantly, inhibition of EGFRtk and ER stress restored eNOS phosphorylation and expression in MRAs of diabetic mice indicating that eNOS expression and activity are regulated by EGFRtk and ER stress-dependent mechanisms. Although ER stress inhibition restored eNOS phosphorylation and expression to the control levels, EDR was partially improved, suggesting that other factors contribute to EDR impairment in MRAs.
Previous reports provided evidence that ER stress increases oxidative stress levels, which represent another mechanism regulating eNOS activity and NO bioavailability. 34, 35 NADPH oxidase seems to be the main source of oxidative stress in animal models of diabetes mellitus. 36 Our data demonstrated that microvascular EDR was improved after the . Endothelial function in mesenteric resistance arteries (MRAs) incubated with apocynin (APO) or N G -nitro-L-arginine methyl ester (l-NAME) from streptozotocin (STZ) mice treated with or without insulin or Tudca and Nox2/4 mRNA levels. A, Endotheliumdependent relaxation in response to acetylcholine (ACh) with and without apocynin (APO) or l-NAME treatments in STZ group, nϭ5. , STZ; e, STZϩl-NAME; s, STZϩAPO. B, Endothelium-dependent relaxation in response to ACh in the presence of apocynin or l-NAME in MRAs from STZϩAG1478 group, nϭ5. ࡗ, STZϩAG1478; छ, STZϩAG1478ϩl-NAME; छSTZϩAG1478ϩAPO. C, Endotheliumdependent relaxation in response to ACh with and without apocynin or l-NAME in STZϩTudca group, nϭ5. OE, STZϩTudca; o, STZϩTudcaϩl-NAME; grey triangle, STZϩTudcaϩAPO. D, Endothelium-dependent relaxation in response to ACh with and without apocynin or l-NAME in the STZϩinsulin group, nϭ5. , STZϩinsulin; OE, STZϩinsulinϩl-NAME; grey circle, STZϩinsulinϩAPO. E, Endothelium-dependent relaxation in response to ACh with and without apocynin or l-NAME treatment in the control group, nϭ5. ࡗ, control; छ, controlϩl-NAME; grey diamond, controlϩAPO. F through I, Nox2 and Nox4 mRNA levels, normalized to 18S rRNA, in all groups, nϭ4 to 6. &PϽ0.05 for STZϩAPO versus STZ.PϽ0.05 for STZ, STZϩAG1478, STZϩTudca, STZϩinsulin, and control vs STZϩl-NAME, STZϩAG1478ϩl-NAME, STZϩTudcaϩl-NAME, STZϩinsulinϩl-NAME and controlϩl-NAME. *PϽ0.05 for STZ vs control or STZϩinsulin. #PϽ0.05 for STZ vs STZϩTudca or STZϩinsulin.
inhibition of NADPH oxidase activity in diabetic mice, whereas no effect was observed in control and diabetic mice treated with EGFRtk and ER stress inhibitors. These data indicate that EGFRtk and ER stress-dependent mechanisms regulate NADPH oxidase activity. These results are supported by the reduction in NADPH oxidase activity and Nox-2 and Nox-4 expression in diabetic mice after EGFRtk and ER stress inhibition. In addition, Nox2 and Nox4 have been shown to be predominantly located in the perinuclear and/or ER membranes, suggesting a relationship between reactive oxygen species generation and ER stress in diabetes mellitus. 37 In conclusion, we demonstrated that, in type 1 diabetes mellitus, the exacerbation in EGFRtk signaling contributes to ER stress induction as a mechanism in part responsible for cardiac fibrosis and microvascular dysfunction. Thus, EGFRtk and ER stress could be potential targets for novel therapeutic strategies to improve cardiovascular function in diabetes mellitus.
Perspectives
Diabetes mellitus is a metabolic disease associated with cardiovascular complications, including cardiac damage and impaired microvascular EDR. Most of clinical studies indicate that diabetic patients are at high risk for cardiovascular diseases. Despite the fact that treatments have progressed, the development of novel effective treatments for diabetic patients with vascular complications remains a major research goal. Therefore, there is a significant medical need to develop novel therapies to restore microvascular endothelial function in these patients. Our results indicate that exacerbated EGFRtk activity and ER stress play key roles in heart damage and vascular dysfunction in type 1 diabetic mice. Interestingly, inhibition of EGFRtk activity decreases ER stress markers, suggesting that ER stress is downstream of the EGFRtk pathway. The inhibition of EGFRtk and ER stress reduces cardiac fibrosis and improves microvascular function associated with enhance in eNOS phosphorylation, cGMP levels, and reduction in NADPH oxidase activity. Therefore, EGFRtk and ER stress could be potential targets for novel therapeutic strategies to improve cardiovascular function in diabetes mellitus.
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